Skip to content

Kimberly-Clark Sees Challenging Year on Persistent Inflation

  • Outlook for earnings and sales falls short of expectations
  • Company sees costs rising by as much as $900 million in 2022
A box of Kimberly-Clark Corp. Kleenex brand tissues.

A box of Kimberly-Clark Corp. Kleenex brand tissues.

Photographer: Daniel Acker/Bloomberg
Updated on

Kimberly-Clark Corp. shares slid after its outlook for 2022 fell short of Wall Street estimates and the company cautioned about a tough year ahead.

Earnings excluding some items will be in the range of $5.60 to $6 a share this year with organic sales growth of 3% to 4%, Kimberly-Clark said in a statement Wednesday. Analysts surveyed by Bloomberg were looking for profit of about $6.72 a share and organic sales growth of about 5.4%.